Our Portfolio
We source and present carefully selected investment opportunities ranging from early stage drug development to established pharmaceutical businesses.
Demonstrating our deal sourcing capabilities, our portfolio currently represents a large number of active global M&A opportunities.
These include promising projects in areas such as specialty pharmaceuticals, consumer health, generics, contract manufacturing and service providers.